APA (7th ed.) Citation

C, B., L, M., S, G., G, M., A, B., E, Z., . . . M, P. (2022). 18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease. Clinical nuclear medicine, 47(6), 525. https://doi.org/10.1097/RLU.0000000000004135

Chicago Style (17th ed.) Citation

C, Bezzi, et al. "18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease." Clinical Nuclear Medicine 47, no. 6 (2022): 525. https://doi.org/10.1097/RLU.0000000000004135.

MLA (9th ed.) Citation

C, Bezzi, et al. "18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease." Clinical Nuclear Medicine, vol. 47, no. 6, 2022, p. 525, https://doi.org/10.1097/RLU.0000000000004135.